These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4164788)

  • 1. Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats.
    Anderson NF; James K; Woodruff MF
    Lancet; 1967 May; 1(7500):1126-8. PubMed ID: 4164788
    [No Abstract]   [Full Text] [Related]  

  • 2. SKIN HOMOGRAFT DESTRUCTION BY "ANTIBODY" DERIVED FROM SENSITIZED LYMPHOID CELLS.
    FELDMAN JD; NAJARIAN JS
    Ann N Y Acad Sci; 1964 Nov; 120():21-5. PubMed ID: 14233867
    [No Abstract]   [Full Text] [Related]  

  • 3. THE EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS.
    WOODRUFF MF; ANDERSON NF
    Ann N Y Acad Sci; 1964 Nov; 120():119-28. PubMed ID: 14233856
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of canine renal allograft survival with antilymphocytic serum.
    Clunie GJ; Nolan B; James K; Watt JG; Woodruff MF
    Transplantation; 1968 May; 6(3):459-67. PubMed ID: 4172547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the mechanism of action of heterologous antilymphocyte globulins].
    Riethmüller G; Rieber P; Riethmüller D
    Klin Wochenschr; 1968 Jan; 46(1):44-6. PubMed ID: 4174966
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of skin homografts by rabbit anti-mouse lymphocyte serum in mice rendered tolerant to rabbit gamma-globulin.
    Howard RJ; Dougherty SF; Mergenhagen SE
    J Immunol; 1968 Aug; 101(2):301-7. PubMed ID: 4174496
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of administration of heterologous antithymus serum to New Zealand rabbits.
    Bitterman W; Shorter RG
    Exp Med Surg; 1968; 26(1-2):43-51. PubMed ID: 4180639
    [No Abstract]   [Full Text] [Related]  

  • 8. An immunosupressive site of action of heterologous antilymphocyte serum.
    Guttmann RD; Carpenter CB; Lindquist RR; Merrill JP
    Lancet; 1967 Feb; 1(7484):248-9. PubMed ID: 4163150
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum.
    Cohen M; Nelken D
    Clin Exp Immunol; 1970 Jan; 6(1):137-44. PubMed ID: 4190337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of heterologous antilymphocytic antiserum in the late prenatal and early postnatal period in mice.
    Jooste SV
    Transplantation; 1968 Mar; 6(2):277-86. PubMed ID: 4172546
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilymphocytic sera and their use in experimental and clinical medicine].
    Gluzman FA
    Klin Khir (1962); 1971 Sep; 9():72-82. PubMed ID: 4107024
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of repeated "therapeutic" courses of antilymphocytic globulin administration on skin allograft survival time in rats.
    Andeson NF; Dalton RG
    Transplantation; 1971 Jul; 12(1):54-6. PubMed ID: 4103650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms common to autoimmune injuries and homograft rejection].
    Voisin GA
    Pathol Biol (Paris); 1969 May; 17(9):509-20. PubMed ID: 4184677
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 15. HETEROLOGOUS MOUSE ANTI-LYMPHOCYTE SERUM TO PROLONG SKIN HOMOGRAFTS.
    GRAY JG; MONACO AP; RUSSELL PS
    Surg Forum; 1964; 15():142-4. PubMed ID: 14189291
    [No Abstract]   [Full Text] [Related]  

  • 16. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature and mode of action of antilymphocytic antiserum.
    Levey RH; Medawar PB
    Proc Natl Acad Sci U S A; 1966 Oct; 56(4):1130-7. PubMed ID: 5339289
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of the indirect fluorescent antibody technique in assessing the activity of antilymphocytic sera and antilymphocytic globulins.
    Thomas D; Mosedale B; Zola H
    Clin Exp Immunol; 1971 Jun; 8(6):987-91. PubMed ID: 4997074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of antilymphoblast globulin in clinical organ transplantation.
    Najarian JS; Merkel FK; Simmons RL; Moore GE
    Br J Surg; 1969 Aug; 56(8):616. PubMed ID: 4183793
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative studies on tissue transplantation immunity. IX. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar P
    Proc R Soc Lond B Biol Sci; 1969 Jul; 173(1033):447-73. PubMed ID: 4389455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.